NIHR | Manchester Biomedical Research Centre

Clinical Research Investment Scheme

The ambition of the Clinical Research Investment Scheme (CRIS) is to invest in and increase the capacity of research-qualified healthcare professionals.

Focusing on experimental medicine and early phase translational research, the CRIS offers healthcare professionals with research experience across the NIHR Manchester Biomedical Research Centre’s NHS partner Trusts the chance to unlock protected research time and access vital project funding.

This unique opportunity supports healthcare professionals in senior roles who may have stepped away from research to focus on clinical work.

What we offer

  • Protected research time
  • Small-scale project funding for research consumables
  • Mentorship and comprehensive training from the NIHR Manchester BRC
  • Core infrastructure support, including public engagement, digital and methodological advice
  • Hands-on skills development in early-phase trials and translational research
A healthcare professional wearing a dark green uniform, white apron, blue gloves and mask is in a clinic room with a research participant who is wearing a white shirt. The research participant is blowing into a white tube.

CRIS aims to provide an opportunity to those who want to build on their existing skillset to pursue a sustainable career in early phase experimental medicine and provide a catalyst for them to continue in research once the scheme has been completed.

Professor George Moulton, Academic Career Development Lead at Manchester BRC, said: “Our Clinical Research Investment Scheme has received an overwhelming amount of interest which clearly highlights the importance and demand for a scheme of this nature within our research community.  It plays a vital role in expanding clinical academic capacity across the next generation of clinical leaders, enabling them to thrive and advance in experimental medicine and early phase translational research across Manchester BRC. We can all look forward to the impactful contributions that will develop from this initiative.”